Update: ASHP statement released.
Survey indicates need for greater pharmacist presence.
FDA approved yet another indication for pembrolizumab (Keytruda) to treat patients with recurrent, locally advanced or metastatic, squamous cell carcinoma of the esophagus (ESCC).
Drug to treat prostate cancer is expected to produce a major windfall for two pharma makers.
How to handle controlled substances and medication safely.
Companies have been promoting unsubstantiated health and treatment claims.
76 billion opioid pain pills distributed from 2012-2016.
Prosecutors are bringing accountability to the opioid epidemic.
FDA approved the first and only ready-to-use insulin for IV infusion in hospitals and acute care settings.
Rule would cost $177 billion through 2029.